次新異動 | 藍月亮漲超2%續創新高,機構預測其有望納入港股通
uSMART盈立智投1月5日消息,週二港股早盤,藍月亮低開高走,截至9:48分,藍月亮漲2.82%,股價最高觸及17.66港元,續創新高。
【藍月亮目前支持10倍槓桿日內交易】
中信證券預測,隨着半年度節點到來,恆生綜指成份股迎來新一輪檢討,屆時港股通股票池也將隨之調整,我們預計有37支標的有望新納入港股通,包括受關注度較高的藍月亮,物業管理板塊的華潤萬象生活、融創服務控股等,正式調整預計將於2021年3月8日生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.